Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
10.15252/emmm.201910865
Saved in:
Main Authors: | Sweeney, M., Corden, B., Cook, S.A. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Review |
Published: |
Blackwell Publishing Ltd
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/199691 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
by: Chen, Y.-T., et al.
Published: (2021) -
The Effectiveness of Non-Pharmacological Interventions in Patients with Heart Failure with Preserved Ejection Fraction
by: AMANDA TAN LI YEE
Published: (2021) -
Large animal models of heart failure: Reduced vs. preserved ejection fraction
by: Charles, C.J., et al.
Published: (2021) -
Circulating neuregulin1-? in heart failure with preserved and reduced left ventricular ejection fraction
by: Hage, C., et al.
Published: (2021) -
Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF
by: Faxen, U. L., et al.
Published: (2022)